Alka Chaubey

CIK: 0001821605

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)6 (75.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BNGO

Bionano Genomics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

BNGO
Bionano Genomics, Inc.
Jun 3, 2026
Tax Payment(F)
Direct
24 shares at avg. $1.30$31.2
BNGO
Bionano Genomics, Inc.
Feb 17, 2026
Tax Payment(F)
Direct
18 shares at avg. $1.10$19.8
BNGO
Bionano Genomics, Inc.
Feb 2, 2026
Award(A)
Stock Option (Right to Buy)
Direct
27.7K shares-
BNGO
Bionano Genomics, Inc.
Sep 11, 2025
Tax Payment(F)
Direct
51 shares at avg. $4.06$207.06
BNGO
Bionano Genomics, Inc.
Jun 3, 2025
Tax Payment(F)
Direct
24 shares at avg. $3.69$88.56
BNGO
Bionano Genomics, Inc.
Mar 14, 2025
Award(A)
Stock Option (Right to Buy)
Direct
7K shares-
BNGO
Bionano Genomics, Inc.
Feb 15, 2025
Tax Payment(F)
Direct
18 shares at avg. $5.73$103.14
BNGO
Bionano Genomics, Inc.
Sep 11, 2024
Tax Payment(F)
Direct
3.1K shares at avg. $0.48$1K

		Type	Shares	Price		Ownership
Jun 3, 2026	BNGO Bionano Genomics, Inc.	Tax Payment(F)	24	$1.30	$31	Direct
Feb 17, 2026	BNGO Bionano Genomics, Inc.	Tax Payment(F)	18	$1.10	$20	Direct
Feb 2, 2026	BNGO Bionano Genomics, Inc.	Award(A) Stock Option (Right to Buy)	27,737	-	-	Direct
Sep 11, 2025	BNGO Bionano Genomics, Inc.	Tax Payment(F)	51	$4.06	$207	Direct
Jun 3, 2025	BNGO Bionano Genomics, Inc.	Tax Payment(F)	24	$3.69	$89	Direct
Mar 14, 2025	BNGO Bionano Genomics, Inc.	Award(A) Stock Option (Right to Buy)	6,966	-	-	Direct
Feb 15, 2025	BNGO Bionano Genomics, Inc.	Tax Payment(F)	18	$5.73	$103	Direct
Sep 11, 2024	BNGO Bionano Genomics, Inc.	Tax Payment(F)	3,075	$0.48	$1,476	Direct

1-8 of 8 transactions

About Chaubey Alka

Chaubey Alka (SEC CIK 0001821605) files insider reports with the SEC as CHIEF MEDICAL OFFICER of Bionano Genomics, Inc. (BNGO).

Signal8 holds 8 ownership filings by Chaubey Alka, all Form 4s, filed between Sep 13, 2024 and Jun 3, 2026. Those filings report 8 transactions, from Sep 11, 2024 to Jun 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Chaubey Alka's filings is in SAN DIEGO, CA.

Recent filings by Chaubey Alka

Jun 3, 2026: Tax withholding of BNGO shares (Form 4, code F).
Feb 17, 2026: Tax withholding of BNGO shares (Form 4, code F).
Feb 2, 2026: Grant or award of BNGO derivative securities (Form 4, code A).
Sep 11, 2025: Tax withholding of BNGO shares (Form 4, code F).
Jun 3, 2025: Tax withholding of BNGO shares (Form 4, code F).

Other insiders filing for Bionano Genomics, Inc. (BNGO)

Luderer Albert, Interim Chief Executive
Adamchak Mark, Principal Accounting Officer
Dixon Jonathan V., General Counsel
OLDAKOWSKI MARK, Chief Operating Officer
Hastie Alex Reid, Chief Scientific Officer
Rajkovic Aleksandar, Director

How to read Form 4 transaction codes